These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38564136)

  • 1. Improving Delivery and Use of HIV Pre-Exposure Prophylaxis in the US: A Systematic Review of Implementation Strategies and Adjunctive Interventions.
    Merle JL; Benbow N; Li DH; Zapata JP; Queiroz A; Zamantakis A; McKay V; Keiser B; Villamar JA; Mustanski B; Smith JD
    AIDS Behav; 2024 Jul; 28(7):2321-2339. PubMed ID: 38564136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods.
    Merle JL; Zapata JP; Quieroz A; Zamantakis A; Sanuade O; Mustanski B; Smith JD
    Addict Sci Clin Pract; 2024 May; 19(1):46. PubMed ID: 38816889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review.
    Li DH; Benbow N; Keiser B; Mongrella M; Ortiz K; Villamar J; Gallo C; Deskins JS; Xavier Hall CD; Miller C; Mustanski B; Smith JD
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S235-S246. PubMed ID: 35703776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Best Practices for Increasing HIV Pre-exposure Prophylaxis (PrEP) Use and Persistence in the United States: A Systematic Review.
    Kamitani E; Higa DH; Crepaz N; Wichser M; Mullins MM;
    AIDS Behav; 2024 Jul; 28(7):2340-2349. PubMed ID: 38743381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence and implication of interventions across various socioecological levels to address pre-exposure prophylaxis uptake and adherence among men who have sex with men in the United States: a systematic review.
    Wang Y; Mitchell JW; Zhang C; Liu Y
    AIDS Res Ther; 2022 Jun; 19(1):28. PubMed ID: 35754038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
    Murewanhema G; Malisheni M; Takah NF
    Pan Afr Med J; 2021; 38():308. PubMed ID: 34178226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POWER Up-Improving pre-exposure prophylaxis (PrEP) uptake among Black cisgender women in the Southern United States: Protocol for a stepped-wedge cluster randomized trial (SW-CRT).
    Ridgway JP; Devlin SA; Friedman EE; Enaholo OE; Pyra M; Hirschhorn LR; Haider S; Ducheny K; Johnson AK
    PLoS One; 2023; 18(5):e0285858. PubMed ID: 37196008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation Strategies to Increase PrEP Uptake in the South.
    Sullivan PS; Mena L; Elopre L; Siegler AJ
    Curr HIV/AIDS Rep; 2019 Aug; 16(4):259-269. PubMed ID: 31177363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-exposure Prophylaxis Uptake, Adherence, and Persistence: A Narrative Review of Interventions in the U.S.
    Garrison LE; Haberer JE
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S73-S86. PubMed ID: 34686294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review.
    Pleuhs B; Quinn KG; Walsh JL; Petroll AE; John SA
    AIDS Patient Care STDS; 2020 Mar; 34(3):111-123. PubMed ID: 32109141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review.
    Bradley E; Forsberg K; Betts JE; DeLuca JB; Kamitani E; Porter SE; Sipe TA; Hoover KW
    J Womens Health (Larchmt); 2019 Sep; 28(9):1272-1285. PubMed ID: 31180253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review.
    Vanhamel J; Rotsaert A; Reyniers T; Nöstlinger C; Laga M; Van Landeghem E; Vuylsteke B
    BMC Health Serv Res; 2020 Jul; 20(1):704. PubMed ID: 32736626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
    Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS
    BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review.
    Dang M; Scheim AI; Teti M; Quinn KG; Zarwell M; Petroll AE; Horvath KJ; John SA
    AIDS Patient Care STDS; 2022 Jun; 36(6):236-248. PubMed ID: 35687813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
    Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Wave HIV Pre-Exposure Prophylaxis Implementation for Gay and Bisexual Men.
    Golub SA; Myers JE
    AIDS Patient Care STDS; 2019 Jun; 33(6):253-261. PubMed ID: 31094576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of Oral Pre-exposure Prophylaxis HIV Adherence Interventions.
    Haines M; Vandyk A; Skidmore B; Orser L; O'Byrne P
    J Assoc Nurses AIDS Care; 2024 Jul-Aug 01; 35(4):309-324. PubMed ID: 38564213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.